免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

OnSite-IV

K 號:K161800 · 2016-12-06

申請人Pharmc, LLC
決定日期2016-12-06
產品代碼LHI
諮詢委員會醫療設備規範文本翻譯如下: HO 注意:原文中未提供具體的醫療設備規範文本,因此上述翻譯僅為示例。請提供完整的規範文本以便進行準確翻譯。
決定相當於

器材摘要

OnSite-IV is the device name listed in this FDA 510(k) record. The listed applicant is Pharmc, LLC. It received FDA 510(k) clearance on 2016-12-06 under 510(k) number K161800. The device is classified under product code LHI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the OnSite-IV?

OnSite-IV is a medical device that received FDA 510(k) clearance on 2016-12-06. The listed applicant is Pharmc, LLC. The 510(k) number is K161800.

When did OnSite-IV receive FDA 510(k) clearance?

OnSite-IV received FDA 510(k) clearance on 2016-12-06, under 510(k) number K161800.

Who is the listed applicant for OnSite-IV?

The FDA 510(k) record lists Pharmc, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for OnSite-IV?

The FDA product code for OnSite-IV is LHI.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:LHI)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑